Abstract
ABSTRACTMost women with epithelial ovarian cancer (EOC) present with late-stage disease. As a result, globally, EOC is responsible for more than 150,000 deaths a year. Thus, a better understanding of risk factors for developing EOC is crucial for earlier screening and detection to improve survival. To that effort, there have been suggestions that there is an association of schizophrenia and cancer, possibly because metabolic changes are a hallmark of both cancer and schizophrenia (SZ). Perturbed choline metabolism has been documented in both diseases. Our objective was to use Mendelian randomization to evaluate whether SZ increased risk for developing EOC or the converse, and, whether SZ impacted glycerophosphocholine (GPC) metabolites. We found that SZ conferred a weak but increased risk for EOC, but not the reverse (no evidence that EOC caused SZ). SZ was also causally associated with lower levels of two GPC species and with suggestively lower levels in an additional three GPCs. We postulate that perturbed choline metabolism in SZ may mimic or contribute to a “cholinic” phenotype, as observed in EOC cells.
Publisher
Cold Spring Harbor Laboratory
Reference32 articles.
1. Risk factors for ovarian carcinoma;Hematol Oncol Clin N Am,2018
2. Global Cancer Statistics, 2002
3. Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis
4. Global cancer statistics, 2012
5. J. Yarmolinsky et al., “Evaluating causal associations between previously reported risk factors and epithelial ovarian cancer: a Mendelian randomization analysis,” bioRxiv, 2018.